FDA Approves Genentech's Avastin Plus Chemotherapy to Treat Type of Ovarian Cancers (RHHBY)
Tweet Send to a Friend
Genentech, a member of the Roche Group (OTC: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
